We have developed an AR endogenous reporter and used this resource together with genome-scale CRISPRi screens to systematically identify networks of genes that sustain AR protein levels and thus the oncogenic activity of AR in PCa. The gene discussed is AR; the disease is posterior cortical atrophy.